Google-backed Isomorphic raises $2.1B for AI-driven drug discovery

Isomorphic Laboratories, the Google DeepMind spinout behind AlphaFold-derived drug discovery pipelines, raised $2.1B to scale AI-driven therapeutic research. This is one of the largest biotech AI rounds to date, reflecting serious institutional confidence in structure-prediction and generative chemistry models translating to clinical pipelines.